Viewing Study NCT01039467



Ignite Creation Date: 2024-05-05 @ 10:06 PM
Last Modification Date: 2024-10-26 @ 10:14 AM
Study NCT ID: NCT01039467
Status: COMPLETED
Last Update Posted: 2020-02-05
First Post: 2009-12-23

Brief Title: A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Organization: Medtronic Cardiac Rhythm and Heart Failure

Study Overview

Official Title: Study of a Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
Status: COMPLETED
Status Verified Date: 2020-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: COMPARE
Brief Summary: The COMPARE-Adapta study is a randomized multi-center prospective study conducted in China The purpose of the study is to compare the ability of Search AV and Managed Ventricular Pacing MVP to reduce ventricular pacing in dual chamber pacemaker-indicated patients The COMPARE-Adapta study will also observe atrial fibrillation AF burden as demonstrated by Cardiac Compass and the clinical profile Adapta pacemaker patients
Detailed Description: Recent studies suggest that chronic right ventricular pacing is associated with a variety of adverse effects in patients particularly those with intact or intermittent atrioventricular AV conduction

Medtronic Adapta pacemakers include Managed Ventricular Pacing a pacing mode designed to promote intrinsic conduction and also Search AV a feature designed to reduce unnecessary ventricular pacing in patients with intact or intermittent AV conduction

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None